Weight-loss drug landscape to change markedly in 2025, bank suggests
A new, more powerful generation of weight-loss drugs could be about the change the landscape for weight-loss treatments, according to analysts at Barclays. Thus far, investors' focus on the GLP-1-based weight loss treatments has ebbed and flowed drugs has ebbed and flowed, but 2025 might be an inflection point in the narrative, suggests the bank.
Evian maker Danone defeats lawsuit over ‘carbon neutral' claim: ‘Technically true'
Consumers accused Danone of defrauding them into buying Evian, not knowing that its manufacturing process allowed the release of carbon dioxide into the atmosphere.
Evian maker Danone defeats lawsuit over 'carbon neutral' claim
The maker of Evian spring water, Danone , won the dismissal of a lawsuit challenging its "carbon neutral" claim on bottles, as a U.S. judge reversed his earlier ruling letting the proposed class action proceed.
Danone wins dismissal of Evian microplastics lawsuit in Chicago
The maker of Evian spring water, Danone , won the dismissal of a lawsuit on Tuesday accusing it of defrauding consumers with labels that claim the water is "natural" even though it contains microplastics that seep from the bottle.
Lifeway Foods rejects Danone takeover offer, adopts shareholder rights plan
Lifeway Foods has declined an unsolicited buyout offer from Danone (OTCQX:DANOY) North America PBC, deeming the bid as undervalued and against the interests of its shareholders. In response, the board of the Illinois-based dairy company adopted a shareholder rights plan to fend off the acquisition attempt, aimed at protecting shareholders from a low-premium takeover.
Danone S.A. (DANOY) Q3 2024 Earnings Conference Call Transcript
Danone S.A. (OTCQX:DANOY) Q3 2024 Earnings Conference Call October 24, 2024 2:15 AM ET Company Participants Mathilde Rodie - IR Juergen Esser - CFO Conference Call Participants Guillaume Delmas - UBS Warren Ackerman - Barclays Celine Pannuti - JPMorgan Charlie Higgs - Redburn Operator Good day, and thank you for standing by.
Danone Sales Growth Beats Market Expectations
The French food company confirmed its full-year guidance after a strong performance in North America and robust growth in sales volumes helped it deliver higher-than-expected organic revenue growth in the third quarter.
Are You Looking for a Top Momentum Pick? Why Danone (DANOY) is a Great Choice
Does Danone (DANOY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are Consumer Staples Stocks Lagging Danone (DANOY) This Year?
Here is how Danone (DANOY) and Symrise AG Unsponsored ADR (SYIEY) have performed compared to their sector so far this year.
New boss is a start, but Nestle's recovery story has big hurdles ahead
How does a benchmark consumer staples giant like Nestle S.A. (OTC:NSRGF, VTX:NESN) reset the agenda and return to growth after a period of losing market share to global competitors like Unilever and Danone (OTCQX:DANOY)?
Danone: There Is Some Upside Left
Danone is undergoing a transformation with positive results, showing potential for a 13-16% annualized RoR. Danone remains an underperforming stock with a 2x variance compared to the market. Despite challenges, Danone is viewed as attractive with a 3.5%+ yield from dairy operations.
Lifeway Foods: Growth Opportunities And Support From Danone Make It A Buy
Lifeway Foods sells kefir, a trending milk-based drink with beneficial properties for intestinal health, with potential for international growth. Lifeway's growth trend is driven by health consciousness, offering a variety of fermented dairy products appealing to health enthusiasts and showing higher growth than competitors. Danone's ownership of 24% of Lifeway creates a symbiotic relationship, with potential for an acquisition.
